Table 1 Description of genotypic data sets used in each part of the analysis
Analysis | IBD mapping: regions with excess of IBD sharing | Association mapping: Two-stage approach | ||
|---|---|---|---|---|
Name | AllMark | NoLD | DOS | WGS |
Type of data | GWAS (65,000, Illumina chips) | Imputed (dosage) WGS based on existing GWAS framework | Whole genome sequence | |
No. markers | ~ 50,000 | 784 | ~1.2 million | ~1.7 million |
No. individuals | 939 | 939 | 464 | |